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Abstract
The impact of syphilis reverse sequence screening has not been evaluated in community outreach. 
Using reverse sequence screening in neighborhoods identified with geographic information 
systems, we found that among 239 participants, 45 (19%) were seropositive. Of these, 3 (7%) had 
untreated syphilis, 33 (73%) had previously treated syphilis infection, and 9 (20%) had negative 
nontreponemal test results.
Highly effective curative strategies for syphilis have been available for more than 50 years, 
but the disease is far from eradication in the United States. In 2008, there were an estimated 
117,000 prevalent syphilis infections in the United States and more than 50,000 incident 
infections.1 Despite a decrease in the national rates of congenital syphilis in 2010, there 
continues to be excess hospitalization costs and morbidity associated with maternal-to-child 
syphilis transmission.2
Persistence of the epidemic has been attributed to “high-transmitters” concentrated in 
specific populations (e.g., men who have sex with men) and/or geographic core areas.3,4 
Current public health efforts focus on targeted syphilis testing for high-risk persons in both 
clinical and community settings.
The mainstay of syphilis diagnosis is serology, traditionally performed by screening with a 
nontreponemal antibody test, such as rapid plasma reagin or toluidine red unheated serum 
test (TRUST), followed by confirmation with a treponemal antibody assay (e.g., Treponema 
pallidum particle agglutination and syphilis-specific IgG enzyme-linked immunosorbent 
assay [EIA]). Many US laboratories have adopted a reverse algorithm for syphilis screening, 
primarily motivated by efforts to increase efficiency and reduce costs with high throughput 
screening.5 With this reverse syphilis screening (RSS) algorithm, samples are screened with 
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an automated treponemal assay such as the EIA followed by nontreponemal testing on 
samples with positive treponemal results.6 If the nontreponemal test result is negative, a 
second treponemal specific test is recommended for further evaluation.7
To our knowledge, the application of the RSS algorithm in community screening programs 
targeting high-risk individuals has not been studied. Implementation of this algorithm faces 
operational barriers in health departments, which have limited resources to conduct patient 
follow-up if a second treponemal test is needed. Although public health programs may have 
disease intervention specialists (DIS) who can trace patients with syphilis to ensure 
treatment and partner notification, their priorities are focused on probable infectious cases to 
prevent disease transmission.8 Furthermore, current US budget reductions have made even 
these resources tenuous.9
The aim of this study was to assess the feasibility and impact of applying the RSS algorithm 
in a high-risk community population identified by geographic information systems incidence 
mapping. Specifically, we sought to quantify the proportion of clinically significant 
(untreated and/or newly diagnosed) syphilis infections identified by the treponemal EIA as 
part of a public health program.
Data for this study were collected with previously described geographic information systems 
methods.10 Briefly, residential addresses of incident tuberculosis, HIV, and syphilis cases in 
Wake County, North Carolina, between 2005 and 2007 were transformed into a kernel 
density map. Community-based syphilis screenings were conducted with Wake County 
Health and Human Services staff from February 6, 2009, to March 11, 2011, in areas with 
the highest densities of all three diseases. Screening sites were chosen based on availability 
of an area within the site to administer confidential surveys and acceptability by the site 
owner. Small incentives (snacks and a US $5 grocery gift card) were used to attract 
participants. Persons were excluded if they were 18 years or younger, did not speak English/
Spanish, or previously participated in the study. Eligible participants were asked to complete 
a verbally administered questionnaire including comorbidities, perceived risk of infection 
and health care use, which have been previously described.11 Participants were screened for 
syphilis symptoms and asked about recent contacts to syphilis cases.
Screening was performed with the T. pallidum–specific IgG EIA (Trep-Sure; Trinity 
Biotech, Jamestown, NY). Specimens with positive EIA results had reflex TRUST testing 
performed. Health department records were reviewed for all cases with positive EIA results 
for evidence of prior infection and/or therapy and previous nontreponemal antibody titers.
Participants were instructed to come to the health department or return to the screening site 
for results. If the results from both the EIA and the TRUST were positive with no 
documentation of prior therapy, standard treatment of syphilis was offered. Participants who 
did not return for test results were actively pursued by DIS according to standard protocols 
based on patient’s age or titers.8 All participants with positive test results were followed up 
for 6 months to determine whether they received appropriate treatment.
The primary outcomes of the study were the proportion of positive treponemal EIAs and the 
proportion of untreated and/or newly diagnosed syphilis infections in our study population. 
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Significance tests for comparisons between seropositive and seronegative participants and 
between patients with and without prior documented treatment included the 2-sample t test 
and Mann-Whitney test for continuous patient characteristics, and Pearson χ2 or Fisher exact 
test for categorical patient characteristics. SAS software, version 9.2 (SAS Institute, Cary, 
NC) was used for all statistical analysis.
The study protocol was approved by the Duke University institutional review board and the 
Wake County Human Rights–Consumer Protection Committee. Written informed consent 
was obtained from each participant.
Of 247 participants recruited, 240 had blood drawn (2 persons left before blood draw and 5 
persons had phlebotomy failures). One participant had an indeterminate treponemal EIA 
result. Among 239 participants with valid EIA results, 45 (19% [95% confidence interval, 
14%–24%]) were seropositive (Fig. 1). Seropositive participants were older (mean age, 49.5 
± 10.5 years) than seronegative participants (mean age, 40.9 ± 12.9 years; P < 0.01). There 
was also a higher proportion of non-Hispanic African Americans (93% vs. 73%, P < 0.01) 
and US-born persons (93% vs. 79%, P = 0.03) in seropositive participants than in 
seronegative participants (Table 1).
Of the 18 participants with both positive treponemal EIA and TRUST results, 15 (83%) had 
a documented history of treated syphilis. Only three participants, all asymptomatic, were 
newly diagnosed as having syphilis (Fig. 1). Two of these patients had a TRUST of 1:2, and 
1 had a TRUST of 1:1, which likely represented cases of late latent syphilis rather than early 
infection. Unfortunately, repeated attempts to contact these patients were not successful after 
6 months of follow-up.
Among the 45 with positive treponemal EIA result, 27 individuals (60%) had negative 
TRUST results (Fig. 1). Eighteen of these 27 persons had documented previous syphilis 
infection with prior therapy. However, 9 had no prior syphilis diagnosis and were 
asymptomatic without known contact to an early syphilis case. DIS attempted to contact 
these 9 persons, but none presented with symptoms or for additional syphilis testing by the 
end of the study period.
The 9 of 27 participants with discordant results and no history of syphilis had similar 
characteristics to the 18 of 27 participants with a history of treated syphilis, with respect to 
age, proportion of black non-Hispanic race, proportion of men, history of incarceration, and 
homelessness. However, the 9 participants reported a lower number of sexual partners 
(median, 1; interquartile range [IQR], 0–1) compared with those with documented prior 
infection/therapy (median, 2; IQR, 1–3; P = 0.05).
In this study using the RSS algorithm among a high-risk community population, we found 
19% seropositivity with the treponemal EIA. This seropositivity rate was higher than rates in 
other studies (2%–4%)7,12 in large part because we screened a targeted high-risk community 
population rather than a clinic population.
Although the RSS algorithm facilitated detection of newly diagnosed syphilis (3/45, or 7%) 
among those tested, we found a high prevalence of previously treated syphilis infections 
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(33/45, or 73%). We identified 12 persons with positive EIA results and no syphilis history 
using health department records. However, despite multiple attempts by DIS to contact these 
persons, none presented for therapy. Implementing newer rapid syphilis tests that 
incorporate both treponemal and nontreponemal antibodies may improve engagement in 
care in these high-risk populations.13,14
This study highlights how the RSS algorithm may not be suitable for screening a population 
with a high prevalence of previously treated syphilis infections. Although our study targeted 
community participants, similar conclusions could be drawn for other high-prevalence 
populations, such as HIV or sexually transmitted disease clinic patients, where the RSS 
algorithm may be more costly than beneficial. RSS may also not be ideal in resource-limited 
public health programs whose priorities are to ensure treatment for individuals with early or 
infectious syphilis.
The study was limited by its small sample size and the nonrandom fashion in which 
participants elected to participate. It is difficult to know whether the high prevalence of prior 
syphilis infection in our study reflected the prevalence in the communities or the higher-risk 
individuals who attended the community-based voluntary screenings. Limited public health 
resources prevented repeat testing with a second treponemal test to distinguish false-positive 
treponemal EIA results,7 but given the high documented prevalence of disease in the 
population, most of the positive test results likely represented true positives. In addition, we 
did not have the resources to conduct nontreponemal tests in addition to the treponemal 
EIAs for screening, which would have facilitated direct comparisons between the RSS 
versus traditional algorithms with respect to the proportion of new or prior syphilis 
infections detected.
Our data suggest that using the RSS for a targeted community screening program among a 
high-prevalence population will primarily find the “footprint” of old syphilis, rather than 
detect cases of public health interest. Although treponemal screening followed by reflex 
nontreponemal titers allowed detection of a few newly diagnosed cases, the impact and cost-
effectiveness of this strategy need further evaluation in public health community-based 
programs.
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Follow-up of syphilis IgG-seropositive participants, Wake County, NC (2009–2011). Of 45 
treponemal IgG-seropositive participants, 18 (40%) had positive nontreponemal test results. 
Of these 18 participants, 15 (83%) had a documented history of syphilis with adequate 
therapy. Only 3 participants, all asymptomatic, were newly diagnosed as having syphilis and 
had no documented history of previous treatment. None of the participants with positive IgG 
and negative TRUST results underwent treatment.
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TABLE 1
Characteristics of Eligible Study Participants by Syphilis Serostatus in Wake County, NC (2009–2012)
Characteristic* All Participants (n = 239)
Syphilis IgG Positive (n 
= 45)
Syphilis IgG Negative (n 
= 194) P†
Mean age (SD), y 42.5 (12.9) 49.5 (10.5) 40.9 (12.9) G0.01
Race‡ 0.02
 Black, non-Hispanic 178 (77) 42 (93) 136 (73) G0.01
 White, non-Hispanic 11 (5) 0 11 (6) 0.13
 Hispanic 42 (18) 3 (7) 39 (21) 0.03
 Native American 3 (1) 0 3 (2) 1.0
Sex 0.50
 Male 140 (59) 24 (53) 116 (60)
 Female 99 (41) 21 (47) 78 (40)
Foreign-born 43 (18) 3 (7) 40 (21) 0.03
Prior incarceration 158 (66) 34 (76) 124 (64) 0.16
Homeless (ever) 90 (38) 21 (47) 69 (36) 0.18
Median (IQR) no. sexual partners in previous 
year
1 (1–3) 1 (1–3) 1 (1–2) 0.54
Values are presented as n (%) or mean (SD) or median (IQR).
*
Totals for each variable may not add up to 100% secondary to observations with missing data.
†
Significance tests for comparisons between syphilis seropositive and seronegative results based on 2-sample t test for parametric, Mann-Whitney 
test for nonparametric continuous patient characteristics, and Pearson χ2 or Fisher exact test for categorical patient characteristics.
‡
Because participants were allowed to report more than 1 race/ethnicity, total categories may exceed 100%.
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